Fund Holdings — Vivo Capital, LLC

Total Portfolio Value:
$892.62M
Total Bought:
$79.93M
Total Sold:
$254.55M
Net Transaction:
-$174.62M
Notable People:
Edgar George Engleman, Frank Fang-Chien Kung, Shan (Nmn) Fu, Michael J. Chang, Gaurav Aggarwal
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Soleno Therapeutics Inc6,291,8516,291,8510$317.68M$282.82M31.68%-$34.86M
Verona Pharma PLCADS3,549,7582,283,975-1,265,783$102.13M$106.07M11.88%+$3.94M
Geron Corporation(GERN)27,225,29227,225,2920$123.60M$96.38M10.80%-$27.23M
Terns Pharmaceuticals Inc6,895,7466,895,7460$57.51M$38.20M4.28%-$19.31M
Avadel Pharmaceuticals PLCADR2,684,1092,684,1090$35.20M$28.21M3.16%-$6.99M
Dyne Therapeutics, Inc.(DYN)1,114,9601,114,9600$40.05M$26.27M2.94%-$13.78M
Aclaris Therapeutics, Inc.(ACRS)08,888,888+8,888,888$0$22.04M2.47%+$22.04M
Delcath Systems, Inc.(DCTH)997,0051,708,579+711,574$9.00M$20.57M2.30%+$11.57M
Viridian Therapeutics, Inc.(VRDN)1,678,207982,576-695,631$38.18M$18.84M2.11%-$19.34M
Cidara Therapeutics, Inc.0670,600+670,600$0$18.03M2.02%+$18.03M
Erasca, Inc.(ERAS)6,756,7566,756,7560$18.45M$16.96M1.90%-$1.49M
Trevi Therapeutics, Inc.(TRVI)1,612,9033,487,903+1,875,000$5.39M$14.37M1.61%+$8.98M
Astria Therapeutics Inc1,552,6851,552,6850$17.10M$13.88M1.56%-$3.21M
Rezolute, Inc.(RZLT)2,797,7042,797,7040$13.57M$13.71M1.54%+$139.9K
Sera Prognostics, Inc.(SERA)1,650,4401,650,4400$12.87M$13.43M1.51%+$561.1K
Tourmaline Bio Inc.591,882591,8820$15.22M$12.00M1.34%-$3.21M
Corvus Pharmaceuticals, Inc.(CRVS)1,497,2682,234,566+737,298$7.91M$11.95M1.34%+$4.05M
Instil Bio, Inc.(TIL)624,339585,485-38,854$42.03M$11.18M1.25%-$30.85M
ORIC Pharmaceuticals, Inc.(ORIC)1,277,8181,277,8180$13.10M$10.31M1.16%-$2.79M
Abeona Therapeutics Inc.(ABEO)1,842,7511,842,7510$11.65M$10.26M1.15%-$1.38M
Zenas BioPharma, Inc.(ZBIO)1,183,2601,183,2600$20.02M$9.69M1.09%-$10.33M
Bright Minds Biosciences Inc.(DRUG)0251,572+251,572$0$9.06M1.02%+$9.06M
Olema Pharmaceuticals, Inc.(OLMA)1,505,8621,505,8620$17.98M$8.78M0.98%-$9.20M
Cogent Biosciences, Inc.(COGT)1,122,4711,122,4710$12.12M$8.76M0.98%-$3.37M
Celcuity Inc.(CELC)610,500610,5000$9.10M$7.99M0.90%-$1.11M
Verastem, Inc.(VSTM)1,538,4611,538,4610$4.60M$7.95M0.89%+$3.35M
Unicycive Therapeutics4,470,1529,970,152+5,500,000$1.82M$7.92M0.89%+$6.09M
Regulus Therapeutics Inc5,000,0005,000,0000$7.85M$7.90M0.89%+$50.0K
Silence Therapeutics plcADS(SLN)1,105,4541,105,4540$20.10M$7.61M0.85%-$12.49M
COMPASS Pathways plcADS(CMPS)1,608,0001,608,0000$10.13M$6.08M0.68%-$4.05M
IO Biotech Inc6,173,4396,173,4390$6.48M$5.68M0.64%-$802.5K
Aligos Therapeutics, Inc.(ALGS)141,879141,8790$1.23M$5.65M0.63%+$4.42M
Compass Therapeutics, Inc.(CMPX)3,556,0233,556,0230$6.54M$5.16M0.58%-$1.39M
Allakos Inc2,956,1102,956,1100$1.93M$3.58M0.40%+$1.65M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)166,794166,7940$3.44M$1.97M0.22%-$1.47M
Bolt Therapeutics Inc3,521,2913,521,2910$2.28M$1.88M0.21%-$397.6K
Tenax Therapeutics, Inc.(TENX)208,333208,3330$720.8K$1.29M0.14%+$568.7K
DBV Technologies S.A.ADS(DBVT)032,020+32,020$0$98.9K0.01%+$98.9K
Q32 Bio Inc.(QTTB)20,55920,5590$917.3K$70.7K0.01%-$846.6K
Precision BioSciences, Inc.(DTIL)4,6754,6750$41.9K$17.8K0.00%-$24.1K
Adverum Biotechnologies, Inc.833,3330-833,333$5.85M$0—-$5.85M
ALX Oncology Holdings Inc.(ALXO)4,034,5220-4,034,522$7.34M$0—-$7.34M
Codexis, Inc.(CDXS)388,1440-388,144$1.20M$0—-$1.20M
DBV Technologies SAADS1,354,4370-1,354,437$948.1K$0—-$948.1K
Engene Holdings Inc.
COM
678,7050-678,705$4.48M$0—-$4.48M
Harmony Biosciences Holdings, Inc.(HRMY)2,606,2470-2,606,247$104.25M$0—-$104.25M
Sinovac Biotech, Ltd.SHS(SVA)11,800,0000-11,800,000$76.35M$0—-$76.35M
Page 1 of 1
Vivo Capital, LLC — 13F Holdings — Q4 2024 | TickerTrail